LYOPHILIZED IMMUNOGLOBULIN FORMULATIONS AND METHODS OF PREPARATION

The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the reco...

Full description

Saved in:
Bibliographic Details
Main Authors BUCKLEY, SHAUN, E, LEHRMAN, SHERWOOD RUSS, BURKE, DAVID, J, O'CONNOR, BARBARA, HORSEY
Format Patent
LanguageEnglish
French
German
Published 31.03.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates generally to the field of pharmaceutical formulation of immunoglobulins. Specifically, the present invention relates to stable, lyophilized, high concentration immunoglobulin formulations. This invention is exemplified by a stabilized lyophilized formulation of the recombinant humanized anti-alpha-4 integrin antibody natalizumab.
Bibliography:Application Number: EP20080771083